Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuankai Shi

Showing results (181-190 of 347) with videos related to

Pageof 35
Sort By:
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 28, 2015
[Clinical features and prognostic analysis of mantle cell lymphoma patients]Ping Zhou, Yuankai Shi, Xiaohui He, et al.
Asia-Pacific Journal of Clinical Oncology|July 3, 2019
A prognostic nomogram constructed for relapsed or refractory diffuse large B-cell lymphoma patientsShiyu Jiang, Yan Qin, Peng Liu, et al.
Annals of Hematology|July 27, 2020
Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphomaHaizhu Chen, Yan Qin, Jianliang Yang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 2, 2003
[Results of combined therapy for 1260 patients with small cell lung cancer]Dongfu Chen, Xiangru Zhang, Weibo Yin, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 12, 2013
[Efficacy of chemotherapy after EGFR-TKIs resistance in 191 patients with Unknow EGFR gene mutation in advanced lung adenocarcinoma]Ping He, Yan Wang, Sheng Yang, et al.
Cytokine|November 14, 2021
Cytokines screening identifies MIG (CXCL9) for postoperative recurrence prediction in operated non-small cell lung cancer patientsNingning Zhang, Qiaoyun Tan, Dan Tao, et al.
Journal of Medical Genetics|June 3, 2010
Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancerYongli Guo, Xuemei Zhang, Ming Yang, et al.
Oncotarget|October 18, 2016
Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern eraQin Wang, Yan Qin, Shengyu Zhou, et al.
Plos One|March 19, 2014
A microRNA signature predicts survival in early stage small-cell lung cancer treated with surgery and adjuvant chemotherapyNan Bi, Jianzhong Cao, Yongmei Song, et al.
Journal of Hematology & Oncology|December 19, 2024
Safety and efficacy of amulirafusp alfa (IMM0306), a fusion protein of CD20 monoclonal antibody with the CD47 binding domain of SIRPα, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a phase 1/2 studyJianliang Yang, Yongping Song, Keshu Zhou, et al.
Pageof 35

Showing results (181-190 of 347) with videos related to

Sort By:
Pageof 35
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 28, 2015
[Clinical features and prognostic analysis of mantle cell lymphoma patients]Ping Zhou, Yuankai Shi, Xiaohui He, et al.
Asia-Pacific Journal of Clinical Oncology|July 3, 2019
A prognostic nomogram constructed for relapsed or refractory diffuse large B-cell lymphoma patientsShiyu Jiang, Yan Qin, Peng Liu, et al.
Annals of Hematology|July 27, 2020
Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphomaHaizhu Chen, Yan Qin, Jianliang Yang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 2, 2003
[Results of combined therapy for 1260 patients with small cell lung cancer]Dongfu Chen, Xiangru Zhang, Weibo Yin, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 12, 2013
[Efficacy of chemotherapy after EGFR-TKIs resistance in 191 patients with Unknow EGFR gene mutation in advanced lung adenocarcinoma]Ping He, Yan Wang, Sheng Yang, et al.
Cytokine|November 14, 2021
Cytokines screening identifies MIG (CXCL9) for postoperative recurrence prediction in operated non-small cell lung cancer patientsNingning Zhang, Qiaoyun Tan, Dan Tao, et al.
Journal of Medical Genetics|June 3, 2010
Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancerYongli Guo, Xuemei Zhang, Ming Yang, et al.
Oncotarget|October 18, 2016
Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern eraQin Wang, Yan Qin, Shengyu Zhou, et al.
Plos One|March 19, 2014
A microRNA signature predicts survival in early stage small-cell lung cancer treated with surgery and adjuvant chemotherapyNan Bi, Jianzhong Cao, Yongmei Song, et al.
Journal of Hematology & Oncology|December 19, 2024
Safety and efficacy of amulirafusp alfa (IMM0306), a fusion protein of CD20 monoclonal antibody with the CD47 binding domain of SIRPα, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a phase 1/2 studyJianliang Yang, Yongping Song, Keshu Zhou, et al.
Pageof 35